ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,618, issued on May 19, was assigned to Georgia Tech Research Corp. (Atlanta) and Board of Regents, The University of Texas System (Austin, Texas).

"Anti-myocilin OLF antibodies and methods of use thereof" was invented by Raquel L. Lieberman (Atlanta), Shannon E. Hill (Lutz, Fla.), Minh Thu Ma (Atlanta), Jennifer A. Maynard (Austin, Texas), Ahlam Qerqez (Austin, Texas) and Laura Azouz Yuan (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Myocilin-binding agents including antibodies and antigen binding fragments thereof and fusion proteins that immunospecifically bind the olfactomedin domain of myocilin. Antibodies that can bind to nativel...